Due to health issues, this site is no longer maintained and will be shut down shortly. |
Eyenovia Inc is a clinical stage biopharmaceutical company. It is engaged in developing a pipeline of ophthalmology products utilizing patented piezo-print technology to deliver micro-therapeutics topically to the eye.
$2.98 0.00 (0.00%)
As of 03/24/2023 16:00:00 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.